logo

 

Print page Print
Close window Close


Health Technology Assessment (HTA) Database

Misoprostol in pregnancy
Malaysian Health Technology Assessment Unit

Record status

This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.

Bibliographic details
Malaysian Health Technology Assessment Unit. Misoprostol in pregnancy. Kuala Lumpur: Malaysian Health Technology Assessment Unit (MHTAU) 2004
Authors' objectives

This assessment determines the safety, effectiveness, cost effectiveness and legal aspects of misoprostol for various uses in the first, second and third trimester for cervical ripening and induction of labour as well as the management of post partum hemorrhage.

Authors' conclusions

Based on the current evidence to date, there is sufficient safety and legal concerns not to recommend misoprostol for cervical priming, termination of pregnancy, induction of labour or postpartum hemorrhage.

URL for original researchhttp://www.moh.gov.my/
Subject index terms statusSubject indexing assigned by CRD
Subject index termsCervical Ripening; Costs and Cost Analysis; Delivery, Obstetric; Labor, Induced; Misoprostol; Postpartum Hemorrhage; Pregnancy
LanguageEnglish
Address for correspondenceHealth Technology Assessment Unit, Medical Development Division, Ministry of Health Malaysia, Level 21, PERKIM Building, Jalan Ipoh, 51200 Kuala Lumpur, Malaysia. Tel: 603 4045 7781, Fax: 603 4045 77 40
Accession number32004000818
Database entry date9 November 2004
© Copyright:

Malaysian Health Technology Assessment Unit (MHTAU)

Close window Close